Australia’s regulator, the Therapeutic Goods Administration (TGA), has implemented several significant regulatory reforms for medical devices and IVDs so far this year, with more on the horizon.
Discover more about medical device labeling, global challenges and how symbols and electronic labeling help provide key information and simplify compliance.
The various MEDDEV guidance associated with the Directives has been tremendously helpful before and even after the IVDR’s release.
The Dutch authorities have published the report of their activities related to post-market surveillance (PMS).
This update features regulatory harmonization and a number of global developments revolving around Unique Device Identifiers (UDI).
Emergo by UL Human Factors Specialists share tips on how to determine external critical design
attributes when conducting threshold analyses.
This feature focuses on what to consider in developing an effective global regulatory strategy. Learning objective 2 during our sponsored RAPS 2024 session titled Navigating and Managing the Global Regulatory Landscape: Strategic Approaches for Success, revolves around a plan for the medical device global regulatory approach.
The regulator in China, the National Medical Products Administration (NMPA), has proposed regulatory reforms to medical devices.